Verastem (NasdaqCM:VSTM) Q4 2025 Earnings call March 04, 2026 04:30 PM ET Company ParticipantsClara Dong - VP of Equity Research in BiotechnologyDan Calkins - CFODan Paterson - President and CEOJulissa Viana - VP of Corporate Communications, Investor Relations, and Patient AdvocacyMatthew Venezia - Biotechnology Equity Research AssociateMichael Kauffman - President of DevelopmentMike Crowther - Chief Commercial OfficerYuan Zhi - Managing DirectorConference Call ParticipantsEric Schmidt - Biotechnology Analy ...

Verastem (NasdaqCM:VSTM) Q4 2025 Earnings call March 04, 2026 04:30 PM ET Speaker10Good afternoon, welcome to Verastem Oncology's fourth quarter and full year 2025 earnings conference call. My name is Desiree, I will be your o-call operator today. Please note this event is being recorded. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. I will now turn the call over to Juliana Viana, Vice President of Corporate Communications, Investo ...